Danielle M. Brander MD completed her medical degree, internal medicine residency training, and fellowship in hematology/oncology at Duke University and Duke University Health System. Her clinical and research focus is in the care of patients with CLL/SLL and she directs the CLL & Lymphoma Clinical Research Program within the Duke Cancer Institute. Dr. Brander has served as site PI for diverse clinical trials of targeted therapeutics for CLL/SLL and other B-cell malignancies, collaborates on initiatives in chronic cancer care with the DCI Onc-Primary Care, and is involved in the National Alliance Cooperative Group in Clinical Trials serving as a Leukemia Committee member & CLL EVOLVE trial champion. She is dedicated to mentoring and medical education activities, as well as patient and caregiver educational initiatives.

Megan joined HealthTree as the Program Manager for CLL in 2022. She is the daughter of a blood cancer patient and has found a passion for helping support patients and caregivers to advance research for their cure and improve their quality of life.